A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms. - Wikidata - awgldk - TriplyDB

A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.

A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.

http://www.wikidata.org/entity/Q38402225

about

Effects of naftopidil on double-J stent-related discomfort: a multicenter, randomized, double-blinded, placebo-controlled study Efficacy of α-blocker in improving ureteral stent-related symptoms: a meta-analysis of both direct and indirect comparison.Combination therapy only shows short-term superiority over monotherapy on ureteral stent-related symptoms - outcome from a randomized controlled trial.The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.Effects of Tamsulosin and Tolterodine on double J stent-related symptoms: A double-blind, randomized, placebo-controlled trial.Prevention and treatment of symptoms associated with indwelling ureteral stents: A systematic review.The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial.Efficacy and safety of tamsulosin oral-controlled absorption system, solifenacin, and combined therapy for the management of ureteric stent-related symptoms.

P2860

Q33830221-DCB2B48C-9DF4-49ED-A393-F0893928CB88 Q36053787-E3D2F7DC-630F-45D2-A4D4-EE1D20BF026C Q36193388-5E816D96-EFCA-4445-9071-34190B5A48D3 Q36383267-5C6F5814-5E40-4034-9326-F77AF632A724 Q37698749-CD3F4375-AA38-43CD-A106-8A0EBE7A45DB Q38942847-19131254-D537-4A13-9D6C-058C8D09E229 Q39158954-A7ABDADB-5F63-4E44-9B60-E99BFFDA4335 Q42399493-0674FD8F-01AF-4405-9E18-FCFC48F9990F

P2860

A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.

http://www.wikidata.org/entity/Q38402225

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A randomized controlled trial ...... eteral stent-related symptoms.

@en

type

label

A randomized controlled trial ...... eteral stent-related symptoms.

@en

prefLabel

A randomized controlled trial ...... eteral stent-related symptoms.

@en

P1433

Q38402225-B7D94284-81C2-42A3-A3FA-009B1FC35F44

P1476

Q38402225-7C8E43D6-0C9E-49A5-97DF-81B65806E392

P2093

Q38402225-38B34C5E-1F9B-4A88-8AAC-2C2F3573A0F2

Q38402225-8D695C43-03B4-4475-B5D4-339B0717EFB5

Q38402225-BB2F851A-08A4-453F-A373-EA3D8E915A18

Q38402225-D8141CCD-DFB4-4F28-8C72-9946E7F09FC9

Q38402225-E34ED5FC-3967-4FB0-BCA1-9E7AD54B9819

P2860

Q38402225-0AE924BA-AF8D-40B2-B9B4-C4B2FD96CED0

Q38402225-0E744353-1E6E-411D-A21E-041B7D42DEF8

Q38402225-11B009C4-7738-42E7-B67A-815AE88D8CEF

Q38402225-13FC074B-2D92-4DF6-9F26-C12EF40057B7

Q38402225-31F564F8-926F-4A47-B53D-8A52D0900127

Q38402225-359F1793-B41B-4E6D-8FED-7E34C53459F4

Q38402225-42964A06-F0BD-4F0C-9BF2-775593F4A809

Q38402225-4988C1C6-934D-49FF-ACB8-FBC805280ED6

Q38402225-517421A1-9727-4C47-AB17-2C92728A08C2

Q38402225-67FEF638-12A3-4C66-ABC7-3F46271244B3

P2888

Q38402225-AF3FA268-5807-4914-9DC0-AE2C61A0340F

P304

Q38402225-73774D59-D7D3-42D9-B5B8-E43D2D1B359C

P31

Q38402225-1777D395-84BC-4A1D-88B6-DE05090A610F

P356

Q38402225-5E38938B-2107-4010-A50D-B7B58CC00E40

P433

Q38402225-03BDB9B4-5B4F-40DC-84D1-D39DCF15B70D

P478

Q38402225-2443F966-F751-4D4A-AC8B-801F59AB3A0F

P577

Q38402225-4C8DE65D-A8F2-4767-BA1A-D49B3219E58D

P6179

Q38402225-86BFC751-5AB5-482E-85F6-79D135731BFA

P698

Q38402225-A64D784B-C0C1-46CB-AB39-B82E511193FA

P356

S00345-015-1704-3

P1433

World Journal of Urology

P1476

A randomized controlled trial ...... eteral stent-related symptoms.

@en

P2093

Ahmed Mosbah

http://www.w3.org/2001/XMLSchema#string

Ahmed R El-Nahas

http://www.w3.org/2001/XMLSchema#string

Mohamed A Gaballah

http://www.w3.org/2001/XMLSchema#string

Mohamed Elsaadany

http://www.w3.org/2001/XMLSchema#string

Mohamed Tharwat

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort.

Is there a role for α-blockers in ureteral stent related symptoms? A systematic review and meta-analysis.

Changes in Urinary Symptoms and Tolerance due to Long-term Ureteral Double-J Stenting.

Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts

Assessing the impact of ureteral stent design on patient comfort

Effects of α-Blockers, Antimuscarinics, or Combination Therapy in Relieving Ureteral Stent-Related Symptoms: A Meta-Analysis.

Validation of the Arabic linguistic version of the Ureteral Stent Symptoms Questionnaire.

The use of stents in contemporary urology.

Randomized controlled trial to compare the safety and efficacy of tamsulosin, solifenacin, and combination of both in treatment of double-j stent-related lower urinary symptoms

Is there a role for alpha1-blockers in treating double-J stent-related symptoms?

P2888

s00345-015-1704-3

P304

963-968

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00345-015-1704-3

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1045951224

http://www.w3.org/2001/XMLSchema#string

P698

26453222

http://www.w3.org/2001/XMLSchema#string